|
Market Cap (18-May) $3,974,759 (1,616th) |
Close (30-Jun) $0.013 |
Volume (30-Jun) 1,163,758 |
Shortsold (28-Jun) 190,931 (0.04%) (531st) |
|
52w High $0.048 |
52w Low $0.015 |
P/E - |
EPS -0.01 |
EXL released this announcement to the ASX on 13 November 2020, 8:40. The announcement is not marked as price sensitive, and is 5 page(s) in length and 294.57kb in size.
You can view all announcements from EXL and see how they appear on a price chart on the announcements page.
At the date of this announcement, EXL was 0.080% short sold according to ASIC data. It was ranked the 431st most shorted stock on the ASX. It remains ranked 531st as of the latest reported data (28 June 2023).
| Other Recent Announcements from EXL | |
|---|---|
| Scheme Booklet registered with ASIC | 29 June 2023, 12:45 |
| TSN: Scheme Booklet registered by ASIC | 29 June 2023, 12:44 |
| TSN: Court orders convening of Scheme Meeting | 29 June 2023, 8:50 |
| Appendix 3Y - Paul Benhaim | 13 November 2020, 8:40 |
| Ceasing to be a Substantial Holder - D&G Health | 13 November 2020, 8:38 |
| Change in Substantial Holding - D&G Health | 13 November 2020, 8:36 |
| Response to ASX Price Query (updated) | 10 November 2020, 13:31 |
You must be logged in to post a reply.
Elixinol Global 